首页 | 本学科首页   官方微博 | 高级检索  
检索        

卡格列净联合阿卡波糖对2型糖尿病患者miR-144、NLRP3 mRNA及MCP-1水平的影响
引用本文:苏海玉,张宏颖,杨俐,张广颖.卡格列净联合阿卡波糖对2型糖尿病患者miR-144、NLRP3 mRNA及MCP-1水平的影响[J].国际检验医学杂志,2022,43(4):420-423,427.
作者姓名:苏海玉  张宏颖  杨俐  张广颖
作者单位:河北省廊坊市人民医院内分泌科,河北廊坊 065000;河北省廊坊市人民医院体检中心,河北廊坊 065000
基金项目:河北省医学科学研究课题计划(20201594)。
摘    要:目的 探讨卡格列净联合阿卡波糖对2型糖尿病患者微小RNA(miR)-144、NOD样受体3炎性小体(NLRP3)mRNA及单核细胞趋化蛋白-1(MCP-1)水平的影响.方法 选取2019年7月至2020年7月该院收治的2型糖尿病患者186例,依据随机数字表法分为单药治疗组、联合治疗组,每组93例.比较两组患者治疗前后血...

关 键 词:卡格列净  阿卡波糖  2型糖尿病  NOD样受体3炎性小体  单核细胞趋化蛋白-1

Effect of canagliflozin combined with acarbose on levels of miR-144,NLRP3 mRNA and MCP-1 in patients with type 2 diabetes mellitus
SU Haiyu,ZHANG Hongying,YANG Li,ZHANG Guangying.Effect of canagliflozin combined with acarbose on levels of miR-144,NLRP3 mRNA and MCP-1 in patients with type 2 diabetes mellitus[J].International Journal of Laboratory Medicine,2022,43(4):420-423,427.
Authors:SU Haiyu  ZHANG Hongying  YANG Li  ZHANG Guangying
Institution:(Department of Endocrinology,Langfang Municipal People′s Hospital,Langfang,Hebei 065000,China;Physical Examination Center,Langfang Municipal People′s Hospital,Langfang,Hebei 065000,China)
Abstract:Objective To investigate the effect of canagliflozin combined with acarbose on the levels of miR-144,NOD like receptor 3 inflammatory corpuscle(NLRP3)mRNA and monocyte chemoattractant protein-1(MCP-1)in the patients with type 2 diabetes mellitus(T2DM).Methods A total of one hundred and eighty-six patients with T2DM in this hospital from July 2019 to July 2020 were selected and divided into the single drug treatment group and combined treatment group according to the random number table method,93 cases in each group.The levels of blood glucose,insulin,inflammatory factors,miR-144,NLRP3 mRNA,MCP-1 before and after treatment and the treatment effect were compared between the two groups.Results Compared with the single drug treatment group,the levels of postprandial 2 h blood glucose(PBG),fasting blood glucose(FPG)and glycosylated hemoglobin(HbA1c)in the combined treatment group were lower(P<0.05).After treatment,the differences of the levels of postprandial 2 h blood glucose and fasting insulin(FINS)in the two groups were not statistically significant(P>0.05).After treatment,the levels of serum interleukin(IL)-1β,IL-17A and IL-23 in the two groups were decreased,the levels of serum IL-1β,IL-17A and IL-23 in the combined treatment group were lower than those in the single drug treatment group(P<0.05).Compared with the single drug treatment group,the levels of serum miR-144,NLRP3 mRNA and MCP-1 after treatment in the combined treatment group were decreased(P<0.05).The treatment effective rate in the combined treatment group was higher than that in the single drug treatment group(P<0.05).Conclusion Adopting canagliflozin combined with acarbose treatment in the patients with T2DM is beneficial to decrease blood glucose,improve the insulin resistance,and has a good efficacy.
Keywords:canagliflozin  acarbose  type 2 diabetes mellitus  NOD like receptor 3 inflammatory corpuscle  monocyte chemoattractant protein-1
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号